Wuxi hiskell medicine infringes the technical patent of Echosens

February 14, 2019 / Meitong news agency / -- Echosens is a French high-tech company engaged in the development, production and sales of FibroScan ® series medical devices (used to evaluate chronic liver disease) Echosens today announced that the Beijing Intellectual Property Court ruled that Wuxi hiskell Medical Technology Co., Ltd (manufacturer of fibrotouch) has zl00805083x owned by Echosens Patent No (which legally protects the FibroScan ® Technology) is infringing According to the ruling, Wuxi hiskell Medical Technology Co., Ltd was sentenced to pay 30 million yuan (equivalent to 3.9 million euros) of damages to Echosens and ordered to stop the production and sale of infringing products in China Mr Laurent sandrin, one of the founders of Echosens, said: "we believe that this judgment will strengthen the protection of intellectual property rights of Echosens in China and fully demonstrate that China is highly consistent with the world in terms of patent technology protection Echosens will remain vigilant and resolutely safeguard its legal rights to ensure the rights and interests of its assets, distributors, employees and shareholders " This ruling is consistent with Echosens's previous ruling in Germany According to the first trial decision on April 20, 2017, the regional court of Dusseldorf, Germany, ruled that Wuxi heskell Medical Technology Co., Ltd violated the patent On March 1, 2018, the higher court of Dusseldorf, Germany, upheld this appeal judgment and prohibited Wuxi heskell Medical Technology Co., Ltd from any sales As a global leader in the field of chronic liver disease diagnosis, Echosens has fundamentally changed the diagnosis of patients with FibroScan, which is a testing equipment with vcte (TM) and cap (TM), a quantitative diagnosis technology of liver steatosis FibroScan ® is a world benchmark in the field of noninvasive liver diagnosis, with more than 2000 related clinical research literatures worldwide and more than 40 recommendations With a large international distribution network including France (Paris), the United States (Waltham) and China (Shanghai, Shenzhen and Beijing), Echosens has installed and used FibroScan ® in more than 80 countries